RGS Protein Regulation of G Protein Coupled Receptors
G 蛋白偶联受体的 RGS 蛋白调节
基本信息
- 批准号:7635827
- 负责人:
- 金额:$ 33.43万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2006
- 资助国家:美国
- 起止时间:2006-07-15 至 2011-06-30
- 项目状态:已结题
- 来源:
- 关键词:ADRBK1 geneAdrenergic AgentsAmino AcidsAnimalsAreaArrestinsBindingBiochemicalBiological AssayBlood VesselsCardiacCardiovascular DiseasesCardiovascular PhysiologyCell NucleusCell membraneCellsCholinergic ReceptorsComplexCouplingCytosolDoctor of PhilosophyEmployee StrikesEndotheliumEventExhibitsFamilyG Protein-Coupled Receptor SignalingG-Protein-Coupled ReceptorsG-substrateGRKGTP-Binding ProteinsGenesGoalsHeart HypertrophyHormonesHuman Cell LineHypertensionKnock-outKnockout MiceKnowledgeLigand BindingLinkMessenger RNAModelingMolecularMolecular ModelsMolecular TargetMusMuscle ContractionMuscle functionNeurotransmittersPhosphorylationPropertyProtein BindingProteinsRGS ProteinsRGS1 geneRGS2 geneRNA InterferenceRecruitment ActivityRegulationResearch PersonnelRoleSignal TransductionSignaling ProteinSmooth MuscleSmooth Muscle MyocytesSolutionsTestingTherapeutic InterventionTissuesWorkadrenergicbasedesensitizationgenetic regulatory proteinhypertension controlmolecular modelingnovelreceptorreceptor bindingtrafficking
项目摘要
DESCRIPTION (provided by applicant): Recent studies with gene knock-out mice indicate a prominent role for the functionally linked signaling proteins RGS2, Gq-alpha (Gqa), alpha-1A-adrenergic (a1A-AR) and m1 muscarininc cholinergic receptors (M1 AChR) in regulation of vascular hypertension, cardiac hypertrophy, sympathetic control of cardiac function, and vascular tone. However, molecular models for how these proteins interact are not well understood. RGS proteins bind directly to activated Ga subunits to modulate and integrate their functions. Very little is known about how RGS selectivity for target Ga is determined in cells. Recent studies suggest that RGS and GPCR are functionally linked in cells but direct interactions have not been shown. Based on these observations, we tested whether RGS proteins and GPCR interact directly. We found that RGS2 (but not RGS1 or RGS16) binds directly and selectively to the third intracellular loop (i3) of the Gq/11-linked M1AChR and a1A-AR, but not i3 of a1B-AR or a1D-AR or Gi/o-linked M2- or M4AChR. Our studies show that RGS2, M1-13, and Gqa form a stable heterotrimer complex, and that the N-terminus of RGS2 is responsible for RGS binding to the i3 of both receptors. My working hypothesis is that RGS proteins form stable, functional complexes with preferred GPCR to selectively modulate the signaling functions of those receptors and linked G proteins. Using molecular, cellular and biochemical approaches, the Specific Aims will be to: Aim 1: Identify amino acids on the M1AChR, a1A-AR and RGS2 responsible for direct binding. Aim 2: Determine roles for RGS2 on receptor/ligand binding and functional Gq/11 a coupling. Aim 3: Determine the effects of RGS2 on GRK2 binding/phosphorylation and arrestin binding to receptors on their desensitization, internalization, and intracellular trafficking. Aim 4: Determine the effects of suppressing native RGS2 mRNA/protein on native M1AChR and a1A-AR signaling functions in cells/VSM tissues that natively expresses a1A-AR or M1AChR and RGS2. These studies will define novel cellular mechanisms for regulating neurotransmitter and hormone signaling, and identify potential new molecular targets for therapeutic intervention in cardiovascular diseases.
描述(由申请人提供):最近对基因敲除小鼠的研究表明,功能相关的信号蛋白RGS 2、Gq-α(Gqa)、α-1A-肾上腺素能(a1 A-AR)和m1毒蕈碱胆碱能受体(M1 AChR)在调节血管性高血压、心脏肥大、心脏功能的交感神经控制和血管紧张性中具有显著作用。然而,这些蛋白质如何相互作用的分子模型还没有得到很好的理解。RGS蛋白直接与活化的Ga亚基结合以调节和整合其功能。很少有人知道如何RGS的目标Ga的选择性是在细胞中确定的。最近的研究表明,RGS和GPCR在细胞中存在功能联系,但尚未显示直接的相互作用。基于这些观察,我们测试了RGS蛋白和GPCR是否直接相互作用。我们发现RGS 2(而不是RGS 1或RGS 16)直接和选择性地结合Gq/11连接的M1AChR和a1 A-AR的第三胞内环(i3),而不是a1 B-AR或a1 D-AR或Gi/o连接的M2-或M4AChR的i3。我们的研究表明,RGS 2,M1-13和Gqa形成稳定的异源三聚体复合物,并且RGS 2的N-末端负责RGS与两种受体的i3结合。我的工作假设是,RGS蛋白与优选的GPCR形成稳定的功能复合物,以选择性地调节这些受体和连接的G蛋白的信号功能。使用分子,细胞和生物化学方法,具体目标将是:目标1:确定负责直接结合的M1AChR,a1 A-AR和RGS 2上的氨基酸。目的2:确定RGS 2在受体/配体结合和功能性Gq/11 a偶联中的作用。目标三:确定RGS 2对GRK 2结合/磷酸化和抑制蛋白结合受体对其脱敏、内化和细胞内运输的影响。目标4:确定抑制天然RGS 2 mRNA/蛋白对天然表达α 1 A-AR或M1 AChR和RGS 2的细胞/VSM组织中天然M1 AChR和α 1 A-AR信号传导功能的影响。这些研究将确定调节神经递质和激素信号的新细胞机制,并确定心血管疾病治疗干预的潜在新分子靶点。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
JOHN R HEPLER其他文献
JOHN R HEPLER的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('JOHN R HEPLER', 18)}}的其他基金
Decoding the RGS14 Interactome/Signalosome in CA2 hippocampal neurons
解码 CA2 海马神经元中的 RGS14 Interactome/Signalosome
- 批准号:
9021004 - 财政年份:2015
- 资助金额:
$ 33.43万 - 项目类别:
Exploring RGS14 signaling functions in the CA2 hippocampus
探索 CA2 海马中的 RGS14 信号传导功能
- 批准号:
8250157 - 财政年份:2011
- 资助金额:
$ 33.43万 - 项目类别:
Exploring RGS14 signaling functions in the CA2 hippocampus
探索 CA2 海马中的 RGS14 信号传导功能
- 批准号:
8322591 - 财政年份:2011
- 资助金额:
$ 33.43万 - 项目类别:
RGS Protein Regulation of G Protein Coupled Receptors
G 蛋白偶联受体的 RGS 蛋白调节
- 批准号:
7460544 - 财政年份:2006
- 资助金额:
$ 33.43万 - 项目类别:
RGS Protein Regulation of G Protein Coupled Receptors
G 蛋白偶联受体的 RGS 蛋白调节
- 批准号:
7860719 - 财政年份:2006
- 资助金额:
$ 33.43万 - 项目类别:
RGS Protein Regulation of G Protein Coupled Receptors
G 蛋白偶联受体的 RGS 蛋白调节
- 批准号:
7261259 - 财政年份:2006
- 资助金额:
$ 33.43万 - 项目类别:
RGS Protein Regulation of G Protein Coupled Receptors
G 蛋白偶联受体的 RGS 蛋白调节
- 批准号:
7142629 - 财政年份:2006
- 资助金额:
$ 33.43万 - 项目类别:
相似海外基金
Preclinical test for the efficacy of adrenergic agents in treatment of AD
肾上腺素能药物治疗AD疗效的临床前试验
- 批准号:
8358448 - 财政年份:2012
- 资助金额:
$ 33.43万 - 项目类别:
Preclinical test for the efficacy of adrenergic agents in treatment of AD
肾上腺素能药物治疗AD疗效的临床前试验
- 批准号:
8517552 - 财政年份:2012
- 资助金额:
$ 33.43万 - 项目类别:
MODULATING FLUID THERAPY WITH ADRENERGIC AGENTS AND CYCLIC AMP ENHANCERS IN
使用肾上腺素能药物和环放大器增强剂调节液体治疗
- 批准号:
7952159 - 财政年份:2009
- 资助金额:
$ 33.43万 - 项目类别:
THE EFFECT OF BETA-ADRENERGIC AGENTS AND FLUID THERAPY IN HUMANS
β-肾上腺素能药物和液体疗法对人体的影响
- 批准号:
7952152 - 财政年份:2009
- 资助金额:
$ 33.43万 - 项目类别:
MODULATING FLUID THERAPY WITH ADRENERGIC AGENTS AND CYCLIC AMP ENHANCERS IN
使用肾上腺素能药物和环放大器增强剂调节液体治疗
- 批准号:
7719194 - 财政年份:2008
- 资助金额:
$ 33.43万 - 项目类别:
THE EFFECT OF BETA-ADRENERGIC AGENTS AND FLUID THERAPY IN HUMANS
β-肾上腺素能药物和液体疗法对人体的影响
- 批准号:
7605416 - 财政年份:2007
- 资助金额:
$ 33.43万 - 项目类别:
MODULATING FLUID THERAPY WITH ADRENERGIC AGENTS AND CYCLIC AMP ENHANCERS IN
使用肾上腺素能药物和环放大器增强剂调节液体治疗
- 批准号:
7605425 - 财政年份:2007
- 资助金额:
$ 33.43万 - 项目类别:
THE EFFECT OF BETA-ADRENERGIC AGENTS AND FLUID THERAPY IN HUMANS
β-肾上腺素能药物和液体疗法对人体的影响
- 批准号:
7378753 - 财政年份:2006
- 资助金额:
$ 33.43万 - 项目类别:
Adrenergic Agents for Methamphetamine: Outpatient Trials
甲基苯丙胺肾上腺素药物:门诊试验
- 批准号:
6825160 - 财政年份:2004
- 资助金额:
$ 33.43万 - 项目类别:
ADRENERGIC AGENTS FOR CARDIOPULMONARY RESUSCITATION
用于心肺复苏的肾上腺素能药物
- 批准号:
2702283 - 财政年份:1997
- 资助金额:
$ 33.43万 - 项目类别: